Professor Gerd Sutter is the Chair of Virology at the Department of Veterinary Sciences of the Ludwig-Maximilians-Universität München.
After graduating in veterinary medicine and obtaining his PhD in Munich, he worked as a postdoctoral scientist with Bernard Moss in the Laboratory of Viral Diseases at the National Institutes of Health, Bethesda MD, USA. Through his later working positions as Research Group Leader at the Institute of Molecular Virology of the Helmholtz Zentrum München and as Director of the Division of Virology at the Paul-Ehrlich-Institut in Langen, he gained a broad knowledge and expertise in the field of research, development and regulation of viral vaccines. Particular emphasis of his research work is on the use of recombinant Modified Vaccinia virus Ankara (MVA) as new vector vaccines against infectious diseases and cancer. Recent studies focused on the prevention of zoonotic and emerging virus infections, e. g. avian influenza, West Nile fever and the Middle East Respiratory Syndrome (MERS). Recently, his research team developed the first vaccine against the MERS coronavirus, which has already successfully been tested in different animal models. In addition, his work concentrates on the fundamental mechanisms of the (pox)viral host interactions, to provide new insights in the molecular life cycle of MVA and the adjuvant-like immunostimulatory properties of MVA when used as vaccine.